LeonaBio, Inc. (LONA) Financials
LONA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 71.6 million | 22.3 million |
| Dec. 31, 2025 | 92.2 million | 64.4 million |
| Sept. 30, 2025 | 30.0 million | 3.2 million |
| June 30, 2025 | 35.5 million | 3.6 million |
LONA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -20.9 million | 662000 |
| Dec. 31, 2025 | -19.4 million | 1.5 million |
| Sept. 30, 2025 | -4.7 million | 1.4 million |
| June 30, 2025 | -7.0 million | 1.6 million |
LONA Net Income
No data available :(
LONA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 67.7 million | 213000 | - |
| Dec. 31, 2025 | 88.3 million | 338000 | - |
| Sept. 30, 2025 | 25.2 million | - | 460000 |
| June 30, 2025 | 29.8 million | - | 1.0 million |
LONA Shares Outstanding
LONA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 11.3 million | 6.9 million | - |
| Dec. 31, 2025 | - | 6.7 million | 3.8 million | - |
| Sept. 30, 2025 | - | 2.6 million | 4.0 million | - |
| June 30, 2025 | - | 3.7 million | 3.6 million | - |
LONA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 68.1 million |
| Sept. 30, 2025 | - | 243000 |
| June 30, 2025 | - | 200000 |
LONA
Price: $8.18
52 week price:
Earnings Per Share: -25.19 USD
P/E Ratio: -0.22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 34.5 million